LOS ANGELES, March 16 /PRNewswire/ -- Medical Tactile, Inc. (MTI) -- a medical device company specializing in tactile sensing technology -- today announced the signing of a long-term partnership agreement with Sino Tau International Co, Ltd. (Beijing) -- one of China’s leading medical device distributors.
Under the terms of agreement, Sino Tau will market, sell and service Medical Tactile’s SureTouch Visual Mapping System in China and other Asian countries (excluding Japan). The agreement involves a minimum of 650 SureTouch units over the next three years, with deliveries beginning during the second quarter of 2006. In addition to serving as Medical Tactile’s primary Asian distributor, Sino Tau will work with the company to initiate a multi-center breast cancer screening clinical trial in China later this year.
“We are pleased to join forces with Sino Tau to launch MTI’s SureTouch system in Asia,” said Steve Weiss, CEO of Medical Tactile, Inc. “Sino Tau understands the region’s large and still-growing market for breast cancer screening, and has the specific clinical and medical device experience necessary to ensure a successful product launch.”
Breast cancer is the leading cause of death for women in China, accounting for about 300,000 deaths each year. The incidence has increased in recent years, from 17 per 100,000 in 1999 to 52 per 100,000 in 2003.
Sino Tau’s Managing Director Bai Ge added, “This alliance represents a significant milestone for Sino Tau in the breast cancer field. The SureTouch system is ideally suited to meeting the demands of the fast growing Asian market.”
Introduced in December 2005, the SureTouch system electronically documents the results of clinical breast exams, which are the most accessible first-line of defense against breast cancer for most women. Based on Medical Tactile’s proprietary tactile sensing technology, the system is designed to improve the sensitivity, specificity and objectivity of such exams.
About Medical Tactile, Inc.
Medical Tactile, Inc. (MTI) is an emerging medical device company focused on developing, manufacturing and marketing tactile sensing technology for the early detection of breast cancer. The Company’s first product is the SureTouch Visual Mapping System, which is designed to improve the sensitivity, specificity and objectivity of manual palpation in breast cancer screening. The system is cleared by the FDA for commercial sale in the U.S. More information about Medical Tactile, Inc. is available at www.medicaltactile.com.
About Sino Tau International Company Limited
Part of an established healthcare group, Beijing-based Sino Tau Intl. has diversified business interests in both medical device and pharmaceutical fields, with expertise in regulatory issues, marketing and sales, OEM and contract research. The company serves as the exclusive Chinese distributor for a range of high-tech medical products with applications in oncology, organ transplantation, diabetes, interventional therapy, liver disease and neurology.
Medical Tactile, Inc.
CONTACT: Erik Deutsch of ExcelPR Group, +1-323-851-2300, ext. 112,erikd@excelpr.com, for Medical Tactile, Inc.
Web site: http://www.medicaltactile.com/
